Showing results (1841-1850 of 1,875) with videos related to
Sort By:
Pageof 188
Journal of Hepatology|May 5, 2021
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)Luca S Belli, Christophe Duvoux, Thierry Artzner, et al.Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.Arthritis Care & Research|October 22, 2014
Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance projectSarah Ringold, Audrey Hendrickson, Leslie Abramson, et al.Frontiers in Immunology|September 3, 2024
Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter studyBerenice Anabel Silva, Esteban Miglietta, Juan Cruz Casabona, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.Science Translational Medicine|October 9, 2024
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axisRong Li, Michela Colombo, Guanlin Wang, et al.Annals of Surgical Oncology|June 25, 2024
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT StudyChirag Shah, Pat Whitworth, Frank A Vicini, et al.Clinical Hematology International|March 15, 2023
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/LymphomaAbdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, et al.Pageof 188